41 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
stock, short-term debt or long-term debt of the Company and its Subsidiary, except in each case as described in each of the Registration Statement … share option, incentive or benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
or long-term voting rights at its shareholders’ meeting and the amount of securities owned by each of them and, where applicable, the restrictions … income tax purposes;
certain former citizens or long-term residents of the United States;
persons that received our ADSs as compensation
F-3
x5yobgopi3a5nr7tm2dm
20 Dec 23
Shelf registration (foreign)
4:45pm
F-3
EX-3.1
0bxdddw8np8z1i
20 Dec 23
Shelf registration (foreign)
4:45pm
6-K
EX-99.1
hxkp3r4d6pzxkb ej893
11 Dec 23
Innate Pharma S.a. 6-K
6:01am
6-K
EX-1.1
j79z55mzn
26 Apr 23
Current report (foreign)
4:02pm
424B5
otyhf3
26 Apr 23
Prospectus supplement for primary offering
4:01pm
6-K
EX-1.1
5jugopefo
3 May 22
Current report (foreign)
5:08pm
424B5
g6t60 ky0zuz
3 May 22
Prospectus supplement for primary offering
4:36pm
6-K
EX-99.1
q0zqis0 ru07
29 Apr 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
spzps 3sgezzvvqe7
16 Nov 21
Innate Pharma S.a. Form 6-K
6:00am
6-K
EX-99.1
crjkqh2ewrck2icps4
15 Sep 21
Innate Pharma Reports First Half 2021 Financial Results and Business Update
6:07am
S-8
EX-4.1
zws8yvc0crahcz0npgcy
12 Jul 21
Registration of securities for employees
1:42pm